Apr 232025
 

From: Nicolas Hulscher, MPH from FOCAL POINTS (Courageous Discourse) <petermcculloughmd@substack.com>
Sent: Wednesday, April 23  ­͏     ­

Forwarded this email? Subscribe here for more

REAKING — RFK Jr. Launches Long-Awaited Offensive Against Deadly COVID-19 mRNA Shots

RFK Jr. breaks silence on mRNA injections — cites risks of myocarditis, stroke, and death on national TV.

Nicolas Hulscher, MPH
Apr 23
READ IN APP
 

By Nicolas Hulscher, MPH

As millions of Americans anxiously await action from the new HHS leadership against the deadly COVID-19 mRNA injections—injected into over 9 million children this year—Robert F. Kennedy Jr. has finally gone publicly on the offensive:

Let’s go over each key point made by RFK Jr.:

The recommendation for children was always dubious. It was dubious because kids had almost no risk for COVID-19. Certain kids that had very profound morbidities may have a slight risk. Most kids don’t.

In the largest review to date on myocarditis following SARS-CoV-2 infection vs. COVID-19 vaccination, Mead et al found that vaccine-induced myocarditis is not only significantly more common but also more severe—particularly in children and young males. Our findings make clear that the risks of the shots overwhelmingly outweigh any theoretical benefit:

The OpenSAFELY study included more than 1 million adolescents and children and found that myocarditis was documented ONLY in COVID-19 vaccinated groups and NOT after COVID-19 infection. There were NO COVID-19-related deaths in any group. A&E attendance and unplanned hospitalization were higher after first vaccination compared to unvaccinated groups:

So why are we giving this to tens of millions of kids when the vaccine itself does have profound risk? We’ve seen huge associations of myocarditis and pericarditis with strokes, with other injuries, with neurological injuries.

The two largest COVID-19 vaccine safety studies ever conducted, involving 99 million (Faksova et al) and 85 million people (Raheleh et al), confirm RFK Jr.’s concerns, documenting significantly increased risks of serious adverse events following vaccination, including:

  1. Myocarditis (+510% after second dose)
  2. Acute Disseminated Encephalomyelitis (+278% after first dose)
  3. Cerebral Venous Sinus Thrombosis (+223% after first dose)
  4. Guillain-Barré Syndrome (+149% after first dose)
  5. Heart Attack (+286% after second dose)
  6. Stroke (+240% after first dose)
  7. Coronary Artery Disease (+244% after second dose)
  8. Cardiac Arrhythmia (+199% after first dose)

And this was clear even in the clinical data that came out of Pfizer. There were actually more deaths. There were about 23% more deaths in the vaccine group than the placebo group. We need to ask questions and we need to consult with parents.

Actually, according to the Pfizer’s clinical trial data, there were 43% more deaths in the vaccine group compared to the placebo group when post-unblinding deaths are included:

We need to give people informed consent, and we shouldn’t be making recommendations that are not good for the population.

Public acknowledgment of the grave harms of COVID-19 vaccines signals that real action is right around the corner. However, we must hope that action is taken for ALL age groups, as no one is spared from their life-reducing effects:

Alessandria et al (n=290,727, age > 10 years): People vaccinated with 2 doses lost 37% of life expectancy compared to the unvaccinated population during follow-up.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

Upgrade to paid

You’re currently a free subscriber to FOCAL POINTS (Courageous Discourse). For the full experience, upgrade your subscription.

Upgrade to paid

 
Like
Comment
Restack
 

© 2025 Peter McCullough MD MPH
548 Market Street PMB 72296, San Francisco, CA 94104
Unsubscribe

 Leave a Reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

(required)

(required)